Search research articles
Contact Us
Filters
Showing results (1-10 of 49) with videos related to
Page
of 5
Sort By:
The Journal of Pediatrics
|
July 13, 2000
Adrenal suppression in children with malignant solid tumors treated with megestrol acetate
C Azcona, L Sierrasesúmaga
Cancer Genetics and Cytogenetics
|
October 6, 1997
Analysis of the p16INK4 and TP53 tumor suppressor genes in bone sarcoma pediatric patients
A Patiño-García, L Sierrasesúmaga
Anales Del Sistema Sanitario De Navarra
|
September 13, 2005
[The cytogenetic assay as a measure of genetic instability induced by genotoxic agents]
M Zalacain, L Sierrasesúmaga, A Patiño
Anales Espanoles De Pediatria
|
May 20, 1998
[Molecular analysis of tumor suppressor genes p16INK4 and TP53 of osteosarcomas in Spanish children]
A Patiño García, L Sierrasesúmaga Ariznabarreta
Anales Del Sistema Sanitario De Navarra
|
May 19, 2004
[Vascular malformations as syndromic markers]
A M Romero, A Echebarría, L Sierrasesúmaga
Anales Del Sistema Sanitario De Navarra
|
July 30, 2003
[Genetic alterations induced by anti-tumour treatments in paediatric patients with cancer: chemical carcinogenesis]
A Patiño, R López de Mesa, L Sierrasesúmaga
Medical and Pediatric Oncology
|
December 24, 1997
Recombinant human erythropoietin for the treatment of anemia in children with solid malignant tumors
P León, M Jiménez, P Barona, et al.
Human Heredity
|
September 1, 1993
Study of HLA antigens in patients with osteosarcoma
P Barona, L Sierrasesúmaga, F Antillón, et al.
Pediatric Research
|
May 15, 1998
p21WAF1 mutation is not a predominant alteration in pediatric bone tumors
A Patiño-García, E Sotillo-Piñeiro, L Sierrasesúmaga-Ariznabarreta
Alimentary Pharmacology & Therapeutics
|
August 1, 1996
Megestrol acetate therapy for anorexia and weight loss in children with malignant solid tumours
C Azcona, L Castro, E Crespo, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 49) with videos related to
Sort By:
Page
of 5
The Journal of Pediatrics
|
July 13, 2000
Adrenal suppression in children with malignant solid tumors treated with megestrol acetate
C Azcona, L Sierrasesúmaga
Cancer Genetics and Cytogenetics
|
October 6, 1997
Analysis of the p16INK4 and TP53 tumor suppressor genes in bone sarcoma pediatric patients
A Patiño-García, L Sierrasesúmaga
Anales Del Sistema Sanitario De Navarra
|
September 13, 2005
[The cytogenetic assay as a measure of genetic instability induced by genotoxic agents]
M Zalacain, L Sierrasesúmaga, A Patiño
Anales Espanoles De Pediatria
|
May 20, 1998
[Molecular analysis of tumor suppressor genes p16INK4 and TP53 of osteosarcomas in Spanish children]
A Patiño García, L Sierrasesúmaga Ariznabarreta
Anales Del Sistema Sanitario De Navarra
|
May 19, 2004
[Vascular malformations as syndromic markers]
A M Romero, A Echebarría, L Sierrasesúmaga
Anales Del Sistema Sanitario De Navarra
|
July 30, 2003
[Genetic alterations induced by anti-tumour treatments in paediatric patients with cancer: chemical carcinogenesis]
A Patiño, R López de Mesa, L Sierrasesúmaga
Medical and Pediatric Oncology
|
December 24, 1997
Recombinant human erythropoietin for the treatment of anemia in children with solid malignant tumors
P León, M Jiménez, P Barona, et al.
Human Heredity
|
September 1, 1993
Study of HLA antigens in patients with osteosarcoma
P Barona, L Sierrasesúmaga, F Antillón, et al.
Pediatric Research
|
May 15, 1998
p21WAF1 mutation is not a predominant alteration in pediatric bone tumors
A Patiño-García, E Sotillo-Piñeiro, L Sierrasesúmaga-Ariznabarreta
Alimentary Pharmacology & Therapeutics
|
August 1, 1996
Megestrol acetate therapy for anorexia and weight loss in children with malignant solid tumours
C Azcona, L Castro, E Crespo, et al.
Page
of 5